Why Canntab

Canntab Therapeutics, The Industry Leader in Solid Oral Dose Therapeutic Cannabis

Innovation, Convenience and Precision Dosing

The Industry Leader in Solid
Oral Dose Therapeutic Cannabis

We are an international biopharmaceutical company that manufactures the only Health Canada approved pharmaceutical grade cannabis in solid oral dose tablets.

Simply put, the future of medical cannabis is here at Canntab Therapeutics.

Our patented technology and best-in-class quality assurance procedures deliver a premium product every time. We make the therapeutic potential of cannabis available to a wide range of customers and patients, seeking alternative therapies for their chronic health conditions.

Patients everywhere face difficult choices when it comes to treating their chronic health conditions – and traditional pharma options can have troubling side effects.

Canntab offers a new option that brings the therapeutic potential of cannabis to those who prefer a more familiar method – solid oral dose tablets and caplets.

Our Portfolio is Expanding. Register now!

Elevation and Enhancement

It releases the active ingredient immediately when it reaches the stomach, meaning the active drug ingredient gets to you quicker than if you were to take an extended release drug that becomes bioavailability later in the digestive system.

Calming Comfort

Gradual in onset and lasting in effect, Canntab’s Extended Release (XR) formulation provides an experience that may benefit you over a prolonged period of time, ideal for the treatment of chronic conditions.

Relief PLUS

Oral disintegrating tablets (ODT) are specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.

Canntab Pharmaceutical Grade Product Design, Production Management and Product Verification

Process and Manufacturing Quality Assurance

Pharmaceutical Grade Product Design, Production Management and Product Verification

Canntab is setting the pharmaceutical-grade standard for medical/therapeutic cannabis product quality and safety.

Quality assurance is at the core of every formulation we create and each shipment we make. Our team is led by experienced professionals who have built their extensive careers in areas such as the manufacturing of pharmaceutical medicines and the implementation of cutting-edge laboratory technologies.

Improved Bioavailability Through Nanotechnology

Bioavailability is the extent to which a substance or drug, as a function of absorption, becomes available to the intended destination in your body.

Nanotechnology is the use of matter on an atomic, molecular, and supramolecular scale for industrial and medical purposes, as in nanomedicine. One of the best applications of nanomedicine is in the area of drug delivery, whereby nanoparticles deliver substances directly to specific cells.

At Canntab, our scientists and formulation experts combine nanotechnology with CBD and THC molecules to create products that improve the bioavailability of these elements in your body. These safe, stable materials are produced on a nanoscale (microscopically small) and optimize the oral route of administration for all of our products.

Canntab Therapeutics, Improved Bioavailability Through Nanotechnology

The Opioid Crisis

Canntab was created, in part, to offer pharmaceutical-grade medical cannabis as an option for highly prescribed medications, and even illegally supplied drugs that have created an overdose crisis in Canada and elsewhere. This is a troubling, even growing public health issue that has greatly increased opioid-related overdoses due to:

  • High rates of opioid prescribing
  • The emergence of strong synthetic opioids in the illegal drug supply – such as fentanyl and carfentanil

What are opioids exactly?

Opioids such as fentanyl, morphine, oxycodone and hydromorphone are medications that can help relieve pain. They affect your mind, mood, and mental processes, so you can experience euphoria, or feeling “high”, which can lead to them being used improperly.

How to get help?

Numerous health and social services are available that can include non-medical therapies. Find out what resources are available in your province.


Canada’s Opioid Crisis continues to plague the country, with over 36,000 deaths or hospitalizations due to overdoses or poisoning from the drug, from January 2016 to March 2020. That’s an average of 23 incidents of death or hospitalization, per day.